Neuroleptic phenothiazines with 1,4-diazabicyclo-[4.4.0]decane and-[4.3.0]nonane Ring System.
D000698:Analgesia; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D006168:Guinea Pigs; D007035:Hypothermia; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010640:Phenothiazines / Q000138:chemical synthesis / Q000494:pharmacology*; D010879:Piperazines / Q000138:chemical synthesis / Q000494:pharmacology; D011083:Polycyclic Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000138:chemical synthesis / Q000494:pharmacology*
D010640:Phenothiazines; D010879:Piperazines; D011083:Polycyclic Compounds; D013565:Sympatholytics; D014149:Tranquilizing Agents